Lilly to Participate in Goldman Sachs Global Healthcare Conference

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

UCB Reports New EADV Data on Bimekizumab Treatment in HS

UCB has announced new three-year data for bimekizumab in...

CPHI Sustainability Summit Targets Practical Pharma Action

CPHI Milan will host the inaugural CPHI Sustainability Summit...

Sterling Expands ADC Manufacturing Capacity and Capabilities

Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions...
- Advertisement -

Eli Lilly and Company (NYSE: LLY) will attend the Goldman Sachs 36th Annual Global Healthcare Conference on Tuesday, June 9, 2015. Jeffrey Simmons, senior vice president and president, Elanco Animal Health, will participate in a fireside chat at 2:20 p.m., Eastern Daylight Time.

A live audio webcast will be available on the “Webcasts & Presentations” section of Lilly’s investor website at http://investor.lilly.com/events.cfm. A replay of the fireside chat will be available for approximately 90 days.

About Eli Lilly and Company

Lilly is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by a man committed to creating high-quality medicines that meet real needs, and today we remain true to that mission in all our work. Across the globe, Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to communities through philanthropy and volunteerism. To learn more about Lilly, please visit us at www.lilly.com and http://newsroom.lilly.com/social-channels.ย  F-LLY

Refer to:

Lauren Zierke; lauren_zierke@lilly.com; (317) 277-6524 (Media)
Phil Johnson; johnson_philip_l@lilly.com; (317) 655-6874 (Investors)

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

UCB Reports New EADV Data on Bimekizumab Treatment in HS

UCB has announced new three-year data for bimekizumab in...

CPHI Sustainability Summit Targets Practical Pharma Action

CPHI Milan will host the inaugural CPHI Sustainability Summit...

Sterling Expands ADC Manufacturing Capacity and Capabilities

Contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions...

eschbach Launches New Digital Leader Standard Work Capability for Pharma Process Operations

Seqonis Intelligent Operations by eschbach has a new dedicated...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป